Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes [Phase 4]
A Phase 4 study comparing patient-driven titration versus investigator-driven titration of biphasic insulin aspart 30 (BIAsp 30) in combinat…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin [Phase 3]
Phase 3 clinical trial update reporting completion of evaluation for a fixed-dose combination of glimepiride and metformin in Chinese adults…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Levemir-Body Composition and Energy Metabolism [Phase 4]
A Phase 4 clinical trial evaluating insulin detemir (Levemir) for effects on body composition and energy metabolism in individuals with Type…
-
CLINICAL_TRIALS research · 2014-05-07Clinical Trial Update: Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment [EARLY_Phase 1]
This entry reports an early-phase trial update evaluating an educational empowerment program for individuals with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing the effects of vildagliptin versus glibenclamide on glycemic response after exercise in adults with Type 2 Diabetes …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: PPP-Botnia Exercise Intervention Study [NA]
Completed PPP-Botnia exercise intervention trial investigating effects in individuals with a family history of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes [NA]
A completed clinical trial update examining inflammatory aspects of glucose in patients with hyperlipidemia and diabetes; conditions include…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone [Phase 3]
A Phase 3 study of dapagliflozin in patients with Type 2 diabetes not well controlled on metformin has completed, with results posted in May…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 study evaluated the safety and efficacy of dapagliflozin as monotherapy in adults with type 2 diabetes, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
This clinical trial update reports the completion and results posting of a study evaluating continuous glucose monitoring in subjects with T…
-
CLINICAL_TRIALS research · 2014-05-02Clinical Trial Update: Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy [Phase 4]
This clinical trial update describes a Phase 4 study evaluating the effect of sequential therapy with insulin followed by exenatide on beta …
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker [Phase 3]
A Phase 3 trial of dapagliflozin (BMS-512148) in adults with type 2 diabetes and inadequately controlled hypertension on an ACE inhibitor or…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine [Phase 1]
Phase 1 study evaluating the effect of multiple doses of isavuconazole on the pharmacokinetics of repaglinide and caffeine in healthy subjec…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: 4 Weeks Treatment of Type II Diabetic Patients With BI 44847 [Phase 1]
A Phase 1 trial evaluating four weeks of BI-44847 in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus [Phase 3]
This document reports the completion of a Phase 3 long-term safety study of TA-7284 in patients with Type 2 Diabetes Mellitus, with results …
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects [Phase 1]
A Phase 1 study assessing safety, tolerability, and pharmacokinetics of single and multiple oral doses of the long-acting GLP-1 analogue sem…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130) [Phase 3]
Clinical trial evaluating sitagliptin added to acarbose in type 2 diabetes mellitus; completed with posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients [Phase 1, Phase 2]
The update reports safety, pharmacokinetics, and pharmacodynamics of TA-7284 in adults with Type 2 diabetes mellitus across Phase 1 and Phas…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes [Phase 4]
Phase 4 study results evaluate exenatide's effects on vessel function in adults with type 2 diabetes mellitus and prediabetes. The results w…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients [Phase 3]
A Phase 3 trial evaluating percutaneous electric neurostimulation of dermatome T7 in obese patients with type 2 diabetes shows an improvemen…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise [NA]
A University of Pittsburgh-led clinical trial investigating mitochondrial dysfunction in type 2 diabetes mellitus and fat oxidation during e…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Intensive Discharge Intervention in Diabetes [NA]
A clinical trial evaluating an intensive discharge intervention for patients with Type 2 diabetes and cardiovascular disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 trial comparing basal-bolus versus basal insulin regimens in type 2 diabetes with hyperglycemia; completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Amiloride for Resistant Hypertension [Phase 4]
Phase 4 trial update evaluating amiloride for resistant hypertension. The study includes individuals with hypertension, type 2 diabetes mell…
-
FDA approval · 2014-04-23FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.